Youth and hormone receptors in breast cancer: good or bad news first?

Lancet. 2000 May 27;355(9218):1839-40. doi: 10.1016/S0140-6736(00)02281-9.
No abstract available

MeSH terms

  • Adult
  • Age Factors
  • Anticarcinogenic Agents / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / metabolism
  • Breast Neoplasms / surgery
  • Combined Modality Therapy
  • Disease-Free Survival
  • Female
  • Humans
  • Middle Aged
  • Ovary / surgery
  • Premenopause
  • Prognosis
  • Receptors, Estrogen / metabolism*
  • Tamoxifen / therapeutic use*

Substances

  • Anticarcinogenic Agents
  • Receptors, Estrogen
  • Tamoxifen